Esaote Group's Commitment to Cardiac Innovation
Esaote Group, a prominent player in medical imaging and diagnostics, is set to showcase its latest advancements at the upcoming European Society of Cardiology (ESC) Congress. This prestigious event represents an opportunity for Esaote to present groundbreaking innovations in cardiovascular imaging technology aimed at enhancing diagnostic precision and streamlining patient care.
Showcase of Advanced Technology
The event will take place at IFEMA in Madrid, where Esaote will present its booth, A280, featuring a comprehensive portfolio of advanced cardiovascular imaging solutions. These technologies are designed to facilitate clinical decision-making throughout the entire care continuum.
MyLab™C30 Cardio System
One of the key highlights is the introduction of the MyLab™C30 cardio—a portable ultrasound system developed specifically for the field of cardiology. This system boasts the largest in its class touchscreen and an intuitive touch interface that enhances usability. Additionally, it incorporates advanced AI-powered tools that drastically reduce examination time while maintaining a high level of diagnostic confidence, even in complex scenarios. With its durable design and extended battery life, this device is perfect for use in both routine checks and emergency situations.
HeartScan Assistant: AI in Cardiac Care
Esaote will also unveil the HeartScan Assistant, an innovative AI-powered feature designed to provide real-time guidance during cardiac ultrasound procedures. This tool empowers healthcare professionals by offering instant feedback on image quality and assists in the classification of views. This resource is especially beneficial for optimizing efficiency in emergency care environments and supporting less experienced cardiologists.
Educational Presentations on Cutting-Edge Techniques
In addition to the technology showcase, Esaote will conduct an insightful presentation focusing on Hyperdoppler techniques and their clinical applications. This presentation is scheduled for a specific time during the congress, providing crucial information on how analyzing force distribution can help identify conditions like dilated cardiomyopathy and assess the impact of resynchronization therapies on heart failure patients.
Healthcare IT Solutions
Esaote's commitment to integrating healthcare IT solutions is evident in its announcement regarding Ebit, the IT division of the company, which will feature the latest enhancements to its Suitestensa CVIS PACS platform. This platform is engineered for both ambulatory and interventional cardiology environments and is equipped with AI-driven tools like fAInd for clinical decision support and ZEfiRO for intelligent workflow automation, ensuring seamless access to patient information.
Revolutionizing Echocardiography
Additionally, the CAAS Qardia echocardiography suite will be showcased, with the upcoming version v2.2 featuring the Qardia View Classifier. This AI-driven assistant is designed to simplify cardiac imaging by pre-selecting the best images for standardized measurements, effectively minimizing the time healthcare professionals spend navigating image sets. Automation of critical echo measurements, such as myocardial strain and cardiac dimensions, will enhance workflow efficiency as well.
Esaote Group's Vision for the Future
Through innovation and a commitment to research and development, Esaote Group aims to continuously advance the field of cardiovascular diagnostics. With operations spanning multiple countries and employing over 1,300 individuals, Esaote maintains a dynamic presence within the global healthcare landscape.
Frequently Asked Questions
What technologies will Esaote showcase at the ESC Congress?
Esaote will showcase the MyLab™C30 cardio portable ultrasound system, the HeartScan Assistant AI feature, and improvements to the Suitestensa CVIS PACS platform.
Where is the ESC Congress taking place?
The ESC Congress will be held at IFEMA in Madrid.
What is the purpose of the HeartScan Assistant?
The HeartScan Assistant provides real-time feedback during cardiac ultrasound procedures, aiding in view classification and image quality assessment.
Who is involved in the development of the CAAS Qardia?
The CAAS Qardia echocardiography suite is developed by Pie Medical Imaging, part of the Esaote Group.
How many employees does Esaote Group have?
Esaote Group employs over 1,300 people, with a significant portion based in Italy.
